{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:49:23Z","timestamp":1777438163930,"version":"3.51.4"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T00:00:00Z","timestamp":1635292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011852","name":"Paracelsus Medizinische Privatuniversit\u00e4t","doi-asserted-by":"publisher","award":["PMU-FFF E-14\/20\/106-ZUR"],"award-info":[{"award-number":["PMU-FFF E-14\/20\/106-ZUR"]}],"id":[{"id":"10.13039\/501100011852","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010729","name":"Carl and Emily Fuchs Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.exer.2021.108806","type":"journal-article","created":{"date-parts":[[2021,10,27]],"date-time":"2021-10-27T06:50:41Z","timestamp":1635317441000},"page":"108806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension"],"prefix":"10.1016","volume":"213","author":[{"given":"Andrea","family":"Trost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Motloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Koller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Bruckner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Runge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Schroedl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Bogner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Kaser-Eichberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Strohmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja-Maria","family":"Ladek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Preishuber-Pfluegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne Maria","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert Anton","family":"Reitsamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108806_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0002-9394(03)00478-1","article-title":"Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma","volume":"136","author":"Anderson","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108806_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/039463200501800208","article-title":"P2Y1 and cysteinyl leukotriene receptors mediate purine and cysteinyl leukotriene co-release in primary cultures of rat microglia","volume":"18","author":"Ballerini","year":"2005","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib4","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/jnc.14070","article-title":"Involvement of microglia in early axoglial alterations of the optic nerve induced by experimental glaucoma","volume":"142","author":"Bordone","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.exer.2021.108806_bib5","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1167\/iovs.07-1337","article-title":"Reduced retina microglial activation and improved optic nerve integrity with minocycline treatment in the DBA\/2J mouse model of glaucoma","volume":"49","author":"Bosco","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1242\/dmm.018788","article-title":"Neurodegeneration severity can be predicted from early microglia alterations monitored in vivo in a mouse model of chronic glaucoma","volume":"8","author":"Bosco","year":"2015","journal-title":"Disease models & mechanisms"},{"key":"10.1016\/j.exer.2021.108806_bib7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/cne.22516","article-title":"Early microglia activation in a mouse model of chronic glaucoma","volume":"519","author":"Bosco","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.exer.2021.108806_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bcp.2009.09.014","article-title":"Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential","volume":"79","author":"Buffo","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1167\/iovs.04-0421","article-title":"The gradient of retinal functional changes during acute intraocular pressure elevation","volume":"46","author":"Bui","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/262467","article-title":"Using the electroretinogram to understand how intraocular pressure elevation affects the rat retina","volume":"2013","author":"Bui","year":"2013","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.exer.2021.108806_bib11","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fcell.2016.00103","article-title":"Evaluation of cysteinyl leukotriene signaling as a therapeutic target for colorectal cancer","volume":"4","author":"Burke","year":"2016","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.exer.2021.108806_bib12","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/brain\/awp147","article-title":"The P2Y-like receptor GPR17 as a sensor of damage and a new potential target in spinal cord injury","volume":"132","author":"Ceruti","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.exer.2021.108806_bib13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nn.2410","article-title":"The oligodendrocyte-specific G protein-coupled receptor GPR17 is a cell-intrinsic timer of myelination","volume":"12","author":"Chen","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2012.09.003","article-title":"Ocular perfusion pressure and ocular blood flow in glaucoma","volume":"13","author":"Cherecheanu","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib15","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.neurobiolaging.2006.06.007","article-title":"The 5-lipoxygenase enzymatic pathway in the mouse brain: young versus old","volume":"28","author":"Chinnici","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.exer.2021.108806_bib16","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1038\/sj.emboj.7601341","article-title":"The orphan receptor GPR17 identified as a new dual uracil nucleotides\/cysteinyl-leukotrienes receptor","volume":"25","author":"Ciana","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.exer.2021.108806_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/sj.bjp.0704189","article-title":"Production of leukotrienes in a model of focal cerebral ischaemia in the rat","volume":"133","author":"Ciceri","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib18","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.survophthal.2019.10.002","article-title":"How many aqueous humor outflow pathways are there?","volume":"65","author":"Costagliola","year":"2020","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108806_bib19","doi-asserted-by":"crossref","first-page":"12088","DOI":"10.1523\/JNEUROSCI.1273-15.2015","article-title":"Soluble tumor necrosis factor Alpha promotes retinal ganglion cell death in glaucoma via calcium-permeable AMPA receptor activation","volume":"35","author":"Cueva Vargas","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083733","article-title":"Rod-like microglia are restricted to eyes with laser-induced ocular hypertension but absent from the microglial changes in the contralateral untreated eye","volume":"8","author":"de Hoz","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108806_bib21","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1167\/iovs.10-5284","article-title":"Microglial activation in the visual pathway in experimental glaucoma: spatiotemporal characterization and correlation with axonal injury","volume":"51","author":"Ebneter","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib22","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.prostaglandins.2012.09.002","article-title":"Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury","volume":"99","author":"Ersahin","year":"2012","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.exer.2021.108806_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174110","article-title":"Neuroprotective and anti-inflammatory effects of a hydrophilic saffron extract in a model of glaucoma","volume":"20","author":"Fernandez-Albarral","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib24","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s11302-013-9366-3","article-title":"Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury","volume":"9","author":"Franke","year":"2013","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.exer.2021.108806_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1742-2094-9-92","article-title":"IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma","volume":"9","author":"Gallego","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108806_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.phrs.2019.02.025","article-title":"Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug","volume":"142","author":"Gelosa","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2021.108806_bib28","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/sj.bjp.0707577","article-title":"Effects of zileuton and montelukast in mouse experimental spinal cord injury","volume":"153","author":"Genovese","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib29","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.exer.2021.108806_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108354","article-title":"Using retinal function to define ischemic exclusion criteria for animal models of glaucoma","volume":"202","author":"Hannon","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib31","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.1523\/JNEUROSCI.0584-17.2017","article-title":"Microglia are irrelevant for neuronal degeneration and axon regeneration after acute injury","volume":"37","author":"Hilla","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood.V81.6.1607.1607","article-title":"Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins","volume":"81","author":"Holness","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.exer.2021.108806_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1742-2094-10-76","article-title":"Deficiency of complement component 5 ameliorates glaucoma in DBA\/2J mice","volume":"10","author":"Howell","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108806_bib34","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1159\/000335793","article-title":"Inhibition of leukotriene receptors boosts neural progenitor proliferation","volume":"28","author":"Huber","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.exer.2021.108806_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1167\/iovs.14-15094","article-title":"Radiation pretreatment does not protect the rat optic nerve from elevated intraocular pressure-induced injury","volume":"56","author":"Johnson","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-2094-11-3","article-title":"Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis","volume":"11","author":"Karlstetter","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108806_bib37","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1167\/iovs.13-11865","article-title":"Effect of anterior chamber cannulation and acute IOP elevation on retinal macrophages in the adult mouse","volume":"54","author":"Kezic","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib38","first-page":"757","article-title":"Effect of montelukast on spinal cord ischemia- reperfusion injury","volume":"25","author":"Korkmaz","year":"2015","journal-title":"Turk Neurosurg"},{"key":"10.1016\/j.exer.2021.108806_bib39","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fphar.2017.00766","article-title":"Role of translocator 18 KDa ligands in the activation of leukotriene B4 activated G-protein coupled receptor and toll like receptor-4 pathways in neutrophils","volume":"8","author":"Kupa","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib40","doi-asserted-by":"crossref","first-page":"e3579","DOI":"10.1371\/journal.pone.0003579","article-title":"The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair","volume":"3","author":"Lecca","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108806_bib41","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5483\/BMBRep.2020.53.1.273","article-title":"Translocator protein (TSPO): the new story of the old protein in neuroinflammation","volume":"53","author":"Lee","year":"2020","journal-title":"BMB Rep"},{"key":"10.1016\/j.exer.2021.108806_bib42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske","year":"2003","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108806_bib43","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1167\/iovs.12-9450","article-title":"Tracking retinal microgliosis in models of retinal ganglion cell damage","volume":"53","author":"Liu","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.exer.2021.108806_bib45","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1167\/iovs.10-5407","article-title":"Glaucomatous tissue stress and the regulation of immune response through glial Toll-like receptor signaling","volume":"51","author":"Luo","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib46","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.exer.2021.108806_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/bs.pmbts.2015.06.010","article-title":"Neuroinflammation in glaucoma and optic nerve damage","volume":"134","author":"Mac Nair","year":"2015","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.exer.2021.108806_bib48","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12974-019-1424-5","article-title":"The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia","volume":"16","author":"Mages","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108806_bib49","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1038\/ncomms9466","article-title":"Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug","volume":"6","author":"Marschallinger","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.exer.2021.108806_bib50","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuint.2005.05.014","article-title":"ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia","volume":"47","author":"Melani","year":"2005","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.exer.2021.108806_bib51","doi-asserted-by":"crossref","first-page":"12633","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor necrosis factor-alpha mediates oligodendrocyte death and delayed retinal ganglion cell loss in a mouse model of glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib52","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.117.8.1050","article-title":"Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma","volume":"117","author":"Neufeld","year":"1999","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108806_bib53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.brainresbull.2003.07.005","article-title":"Pharmacologic neuroprotection with an inhibitor of nitric oxide synthase for the treatment of glaucoma","volume":"62","author":"Neufeld","year":"2004","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.exer.2021.108806_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/13543776.2019.1665023","article-title":"Adrenergic agonists and antagonists as antiglaucoma agents: a literature and patent review (2013-2019)","volume":"29","author":"Nocentini","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.exer.2021.108806_bib55","article-title":"Neuronal activity increases translocator protein (TSPO) levels","author":"Notter","year":"2020","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.exer.2021.108806_bib56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbrc.2017.01.052","article-title":"The selective cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast regulates extracellular matrix remodeling","volume":"484","author":"Peng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.exer.2021.108806_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2006.02.002","article-title":"Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders","volume":"52","author":"Phillis","year":"2006","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.exer.2021.108806_bib58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","article-title":"The role of microglia in retinal neurodegeneration: alzheimer's disease, Parkinson, and glaucoma","volume":"9","author":"Ramirez","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib59","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fncel.2017.00254","article-title":"Optic nerve degeneration after retinal ischemia\/reperfusion in a rodent model","volume":"11","author":"Renner","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040065","article-title":"Etanercept, a widely used inhibitor of tumor necrosis factor-alpha (TNF-alpha), prevents retinal ganglion cell loss in a rat model of glaucoma","volume":"7","author":"Roh","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.exer.2021.108806_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1742-2094-11-133","article-title":"Microglia in mouse retina contralateral to experimental glaucoma exhibit multiple signs of activation in all retinal layers","volume":"11","author":"Rojas","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108806_bib62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11064-014-1478-9","article-title":"Montelukast, a cysteinyl leukotriene receptor-1 antagonist protects against hippocampal injury induced by transient global cerebral ischemia and reperfusion in rats","volume":"40","author":"Saad","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.exer.2021.108806_bib63","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1167\/iovs.09-3921","article-title":"A novel method for the induction of experimental glaucoma using magnetic microspheres","volume":"52","author":"Samsel","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib64","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-015-0422-5","article-title":"Targeting translocator protein (18 kDa) (TSPO) dampens pro-inflammatory microglia reactivity in the retina and protects from degeneration","volume":"12","author":"Scholz","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.exer.2021.108806_bib65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00441-013-1666-y","article-title":"The role of Muller glia and microglia in glaucoma","volume":"353","author":"Seitz","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.exer.2021.108806_bib66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000312669","article-title":"Cysteinyl leukotrienes and their receptors: molecular and functional characteristics","volume":"85","author":"Singh","year":"2010","journal-title":"Pharmacology"},{"key":"10.1016\/j.exer.2021.108806_bib67","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a017269","article-title":"The complex role of neuroinflammation in glaucoma","volume":"4","author":"Soto","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.exer.2021.108806_bib68","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1167\/iovs.05-0830","article-title":"Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes","volume":"47","author":"Stasi","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib69","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00441-013-1637-3","article-title":"Status and perspectives of neuroprotective therapies in glaucoma: the European glaucoma society white paper","volume":"353","author":"Tamm","year":"2013","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.exer.2021.108806_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/02713683.2014.922194","article-title":"Age of rats seriously affects the degree of retinal damage induced by acute high intraocular pressure","volume":"40","author":"Tan","year":"2015","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.10.1.22","article-title":"When is a control not a control? Reactive microglia occur throughout the control contralateral pathway of retinal ganglion cell projections in experimental glaucoma","volume":"10","author":"Tribble","year":"2021","journal-title":"Translational vision science & technology"},{"key":"10.1016\/j.exer.2021.108806_bib72","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exer.2017.03.003","article-title":"Lymphatic and vascular markers in an optic nerve crush model in rat","volume":"159","author":"Trost","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exer.2015.05.010","article-title":"Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension","volume":"136","author":"Trost","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib74","doi-asserted-by":"crossref","first-page":"10512","DOI":"10.1523\/JNEUROSCI.5183-12.2013","article-title":"Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease","volume":"33","author":"Valera","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.exer.2021.108806_bib75","first-page":"1088","article-title":"Immunohistologic evidence for retinal glial cell changes in human glaucoma","volume":"43","author":"Wang","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib76","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/jnr.24256","article-title":"Neuroinflammation and microglia in glaucoma: time for a paradigm shift","volume":"97","author":"Wei","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2021.108806_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Neuroinflammation in glaucoma: a new opportunity","author":"Williams","year":"2017","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108806_bib78","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3109\/09273948.2013.806989","article-title":"Improved retinal ganglion cell survival through retinal microglia suppression by a Chinese herb extract, triptolide, in the DBA\/2J mouse model of glaucoma","volume":"21","author":"Yang","year":"2013","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.exer.2021.108806_bib79","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1167\/iovs.11-8152","article-title":"Neurodegenerative and inflammatory pathway components linked to TNF-alpha\/TNFR1 signaling in the glaucomatous human retina","volume":"52","author":"Yang","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108806_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000081072","article-title":"Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice","volume":"73","author":"Yu","year":"2005","journal-title":"Pharmacology"},{"key":"10.1016\/j.exer.2021.108806_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/aps.2013.130","article-title":"Cysteinyl leukotriene receptor 1 mediates LTD4-induced activation of mouse microglial cells in vitro","volume":"35","author":"Yu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.exer.2021.108806_bib82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head","volume":"32","author":"Yuan","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.exer.2021.108806_bib83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/jnr.1104","article-title":"Activated microglia in the human glaucomatous optic nerve head","volume":"64","author":"Yuan","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.exer.2021.108806_bib84","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.113.203604","article-title":"HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation","volume":"346","author":"Zhang","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.exer.2021.108806_bib85","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuroscience.2011.11.066","article-title":"The new P2Y-like receptor G protein-coupled receptor 17 mediates acute neuronal injury and late microgliosis after focal cerebral ischemia in rats","volume":"202","author":"Zhao","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2021.108806_bib86","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.2042-7158.2010.01238.x","article-title":"Montelukast, a cysteinyl leukotriene receptor-1 antagonist, attenuates chronic brain injury after focal cerebral ischaemia in mice and rats","volume":"63","author":"Zhao","year":"2011","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.exer.2021.108806_bib87","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1213\/ANE.0000000000000174","article-title":"Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury","volume":"118","author":"Zhou","year":"2014","journal-title":"Anesth. Analg."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521003729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521003729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:13:09Z","timestamp":1757999589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521003729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":87,"alternative-id":["S0014483521003729"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108806","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108806","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108806"}}